Search results
Results from the WOW.Com Content Network
Levodopa-induced dyskinesia (LID) is a form of dyskinesia associated with levodopa (l-DOPA), used to treat Parkinson's disease. It often involves hyperkinetic movements, including chorea, dystonia, and athetosis. [1] In the context of Parkinson's disease (PD), dyskinesia is often the result of long-term dopamine therapy.
Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa. [6] It is primarily used to manage the symptoms of Parkinson's disease, but it does not slow down the disease or stop it from getting worse. [6]
The symptoms can be acute (short-term) or chronic (long-term). They include movement dysfunction such as dystonia (continuous spasms and muscle contractions), akathisia (may manifest as motor restlessness), [ 1 ] parkinsonism characteristic symptoms such as rigidity , bradykinesia (slowness of movement), tremor , and tardive dyskinesia ...
A new study found that Parkinson's disease patients who took dance classes experienced fewer symptoms of depression, with dance having "a positive effect on the mood circuits in the brain ...
Neil Diamond says it's been a process accepting his 2018 Parkinson's disease diagnosis. The "Sweet Caroline" singer-songwriter, 82, discussed his legendary career and health in a CBS Sunday ...
Even deficiencies in nutrients such as iron and vitamin B12 can make you feel less stable on your feet. Several medical conditions – including diabetes, arthritis, Parkinson ... symptoms can ...
The rebound effect, or pharmaceutical rebound phenomenon, is the emergence or re-emergence of symptoms that were either absent or controlled while taking a medication, but appear when that same medication is discontinued, or reduced in dosage. In the case of re-emergence, the severity of the symptoms is often worse than pretreatment levels.
When compared with levodopa, while they delay motor complications, they control worse symptoms. [3] Nevertheless, they are usually effective enough to manage symptoms in the initial years. [9] They are also more expensive. [9] Dyskinesias with dopamine agonists are rare in younger patients, but along other side effects, more common in older ...